105 related articles for article (PubMed ID: 21889114)
1. Association of copy number loss of CDKN2B and PTCH1 with poor overall survival in patients with pulmonary squamous cell carcinoma.
Zhao Y; Li Y; Lu H; Chen J; Zhang Z; Zhu ZZ
Clin Lung Cancer; 2011 Sep; 12(5):328-34. PubMed ID: 21889114
[TBL] [Abstract][Full Text] [Related]
2. The relationship between EGFR gain and VHL loss in lung adenocarcinoma and poor patient survival.
Zhao Y; Li Y; Wang S; Lu H; Chen J; Zhang Z; Jin Y; Zhu ZZ
Int J Clin Oncol; 2011 Dec; 16(6):679-85. PubMed ID: 21556796
[TBL] [Abstract][Full Text] [Related]
3. Estimation of the Survival of Patients With Lung Squamous Cell Carcinoma Using Genomic Copy Number Aberrations.
Cao Y; Liu Y; Yang X; Liu X; Han N; Zhang K; Lin D
Clin Lung Cancer; 2016 Jan; 17(1):68-74.e5. PubMed ID: 26427646
[TBL] [Abstract][Full Text] [Related]
4. Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma.
Sriram KB; Larsen JE; Savarimuthu Francis SM; Wright CM; Clarke BE; Duhig EE; Brown KM; Hayward NK; Yang IA; Bowman RV; Fong KM
PLoS One; 2012; 7(2):e30398. PubMed ID: 22363434
[TBL] [Abstract][Full Text] [Related]
5. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.
Lee E; Moon JW; Wang X; Kim C; Li S; Shin BK; Jung W; Kim HK; Kim HK; Lee JY
Hum Pathol; 2015 Aug; 46(8):1111-20. PubMed ID: 26003479
[TBL] [Abstract][Full Text] [Related]
6. [Copy number aberrations of genes related to extrohepatic metastasis-free survival after operation for hepatocellular carcinoma].
Bao LL; Zhu ZZ; Wen BJ; Wan XX; Ye YQ; Chen L; He SQ; Cong WM
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):349-353. PubMed ID: 28763841
[No Abstract] [Full Text] [Related]
7. Inactivation of 9q22.3 tumor suppressor genes predict outcome for patients with head and neck squamous cell carcinoma.
Ghosh A; Maiti GP; Bandopadhyay MN; Chakraborty J; Biswas J; Roychoudhury S; Panda CK
Anticancer Res; 2013 Mar; 33(3):1215-20. PubMed ID: 23482805
[TBL] [Abstract][Full Text] [Related]
8. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
[TBL] [Abstract][Full Text] [Related]
9. Correlation of hedgehog signal activation with chemoradiotherapy sensitivity and survival in esophageal squamous cell carcinomas.
Zhu W; You Z; Li T; Yu C; Tao G; Hu M; Chen X
Jpn J Clin Oncol; 2011 Mar; 41(3):386-93. PubMed ID: 21127038
[TBL] [Abstract][Full Text] [Related]
10. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
11. Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma.
Sinha S; Singh RK; Alam N; Roy A; Roychoudhury S; Panda CK
Mol Cancer; 2008 Nov; 7():84. PubMed ID: 18990233
[TBL] [Abstract][Full Text] [Related]
12. Genomic copy-number alterations of MYC and FHIT genes are associated with survival in esophageal squamous-cell carcinoma.
Miyawaki Y; Kawachi H; Ooi A; Eishi Y; Kawano T; Inazawa J; Imoto I
Cancer Sci; 2012 Aug; 103(8):1558-66. PubMed ID: 22578181
[TBL] [Abstract][Full Text] [Related]
13. Activation of the sonic hedgehog pathway and its prognostic impact in patients with gastric cancer.
Saze Z; Terashima M; Kogure M; Ohsuka F; Suzuki H; Gotoh M
Dig Surg; 2012; 29(2):115-23. PubMed ID: 22456124
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of CDKN2B is involved in poor gastric cancer prognosis.
Chen X; Yu X; Shen E
J Cell Biochem; 2019 Dec; 120(12):19825-19831. PubMed ID: 31297846
[TBL] [Abstract][Full Text] [Related]
15. Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma.
Yokobori T; Mimori K; Iwatsuki M; Ishii H; Tanaka F; Sato T; Toh H; Sudo T; Iwaya T; Tanaka Y; Onoyama I; Kuwano H; Nakayama KI; Mori M
Int J Oncol; 2012 Jul; 41(1):253-9. PubMed ID: 22576686
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of chromosomal imbalances in squamous cell carcinoma and adenocarcinoma of the lung.
Danner BC; Hellms T; Jung K; Gunawan B; Didilis V; Füzesi L; Schöndube FA
Ann Thorac Surg; 2011 Sep; 92(3):1038-43. PubMed ID: 21871296
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
Kim HR; Kim DJ; Kang DR; Lee JG; Lim SM; Lee CY; Rha SY; Bae MK; Lee YJ; Kim SH; Ha SJ; Soo RA; Chung KY; Kim JH; Lee JH; Shim HS; Cho BC
J Clin Oncol; 2013 Feb; 31(6):731-7. PubMed ID: 23182986
[TBL] [Abstract][Full Text] [Related]
18. Loss of 3p26.3 is an independent prognostic factor in patients with oral squamous cell carcinoma.
Uchida K; Oga A; Nakao M; Mano T; Mihara M; Kawauchi S; Furuya T; Ueyama Y; Sasaki K
Oncol Rep; 2011 Aug; 26(2):463-9. PubMed ID: 21617881
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of liberated domain I of the urokinase plasminogen activator receptor in squamous cell lung cancer tissue.
Almasi CE; Høyer-Hansen G; Christensen IJ; Danø K; Pappot H
Lung Cancer; 2005 Jun; 48(3):349-55. PubMed ID: 15893003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
